Employer Resources

Insights to help you hire and manage your workforce

This discussion features DEIB leaders from California Life Sciences, MassBio, Eli Lilly and Takeda. We explore changing attitudes in the life sciences workforce, if organizations are adjusting either their DEIB or communication strategies, and how evolving philosophies around DEIB are impacting human resources and talent acquisition activities.
Labor Market Trends
New York City has seen increased life sciences employment during the past decade as public funding and key projects like JLABS @ NYC have given the area a boost. A Partnership Fund for New York City executive discusses the city’s strengths and a notable challenge facing businesses.
Data scientist employment is expected to grow 33.5% from 2024 to 2034 due in part to a growing demand for data analysis, according to new U.S. Bureau of Labor Statistics findings. Biopharma hotspots were among the top 10 states for employment and pay for this role in 2024.
Massachusetts biopharma workforce growth was fairly flat last year, and R&D and manufacturing employment declined, according to a new MassBio report. BioSpace data further highlight challenges facing the state, showing roughly 2,300 people out of work in 2025 and jobs live on the website falling.
BioSpace has named 50 biopharma companies to its 2025 Best Places to Work list, including Moderna and Sutro Biopharma, whose executives share what makes their organizations special.
BioSpace’s third report on diversity, equity, inclusion and belonging in life sciences examines dramatic shifts in attitude around diversity initiatives.
A new BioSpace report finds that life science professionals are prioritizing diversity less when job hunting. Still, DEIB programs don’t appear to be going anywhere.
Both the White House and Congress have proposed legislation for the appropriate use of AI while the FDA continues to serve as the gatekeeper for patient privacy and safety.
BioSpace was thrilled to host a virtual panel discussion to hear how workplaces can improve their D&I strategies and help organizations thrive. We heard insightful advice from panelists from Amgen, Intellia Therapeutics, Obsidian Therapeutics, Omega Therapeutics and Athira Pharma.
RECRUITING
To successfully compete against one another and Big Pharma for top talent, biotech companies need to do a better job of selling themselves.
If we want to make the UK a scientific superpower, we need to address the elephant in the room: the skills gap.
James Ellis, an authority on employer branding for small businesses and biotechs, weighs in on the best ways to earn candidates’ trust.
As the market recovers from the effects of the COVID-19 pandemic, employers are beginning to regain some of the power they lost in recruiting, forcing candidates to adjust their asks.
Providing extra benefits and perks to parents in the workplace can be polarizing, but it doesn’t have to be.
Scott Rivers, president and managing partner of an executive search and talent branding firm, weighs in on what managers can do to keep top talent.
BioSpace’s 2024 Salary Report explores the average salaries and salary trends of life sciences professionals.
WEBINARS
This webinar highlights practical strategies to overcome two key challenges in TCR discovery: poor expression and low affinity. Discover how the innovative WuXian Transient™ system enables high-titer CHO production of sTCRs (~100 mg/L) and TCR-TCEs, and how optimized phage-based affinity maturation routinely delivers ~10,000-fold KD improvements. Through real-world case studies, see how these integrated solutions generate high-quality TCR building blocks in a high-throughput manner, streamlining the path to next-gen TCR-TCE therapeutics.